Odds of Opioid Prescriptions Up in Head and Neck Cancer Patients
More oxycodone tablets provided per prescription for HNCA versus lung and colon cancer
Median Household Income Predicts Survival in Anal Cancer
Lower income tied to worse overall, cancer-specific survival in squamous cell carcinoma of the anus
NCCN Recommends New Drugs Beyond FDA-Approved Indications
NCCN recommended 47 FDA-approved drugs for 113 indications; 39 percent were extra recommendations
Doctors Facing Challenge to Help Needy While Protecting Practices
Many practices are finding it difficult to maintain their viability while caring for patients who can't pay
Most Women Willing to Trade Off Benefits, Risks of Breast Screening
Women are willing to accept 1.72 additional unnecessary follow-ups and willing to pay £79.17
No Benefit for Aggressive Therapy in Metastatic Prostate Cancer
However, mortality higher with conservative therapy in locally advanced, non-metastatic prostate cancer
AAOS: Stem Cell Tx for Knee OA Costs About $5,000 Per Injection
High cost, rapidly expanding use despite low-level evidence; mean marketed clinical efficacy of 82.2%
Single PSA Screening Doesn’t Cut Prostate Cancer Mortality
But screening is associated with increased detection of low-risk prostate cancer
Limited Evidence for Clinical Validity, Utility of ctDNA
No evidence for circulating tumor DNA assays in early-stage cancer, residual disease detection
Excretion of Volatile Organic Compounds Up in Teen E-Smokers
Excretion of metabolites of acrylonitrile, acrolein, propylene oxide, acrylamide, crotonaldehyde up
